论文部分内容阅读
加《医学邮报》第16卷第22期(1980年)报道美国布法罗消息:据滝太广(Hiroshi Takita)医生称,对不能手术的肺癌用合并疗法治疗取得了初步的结果。罗斯韦尔·帕克纪念研究所胸外科付主任滝太广说,24名患者接受了以顺式二胺二氯铂为基础的合并化疗,进而采用一些可能利用的疗法,放射治疗、肺切除、化疗和免疫疗法。其中20名患者从化疗开始生存了7～33个月,4名患者在肺切除后生存27个月。
Plus, Medical Post, Vol. 16, No. 22 (1980) reports on US Buffalo. According to Dr. Hiroshi Takita, preliminary results were obtained for the treatment of inoperable lung cancer with combination therapy. According to director of the Department of Thoracic Surgery, Roswell Parker Memorial Institute, 24 patients received chemotherapy with cis-diamine-dichloroplatinum-based chemotherapy, and then used some possible treatments, such as radiation therapy and lung resection. Chemotherapy and immunotherapy. Of these, 20 patients survived for 7 to 33 months from chemotherapy, and 4 patients survived 27 months after lung resection.